Scheduling of ultra low dose interleukin-2 in immunotherapy.
Lindemann
A
A
Mertelsmann
R
R
D000279:Administration, Cutaneous; D006801:Humans; D007167:Immunotherapy; D007376:Interleukin-2 / Q000008:administration & dosage*; D007694:Killer Cells, Natural / Q000276:immunology; D007958:Leukocyte Count; D009369:Neoplasms / Q000628:therapy
D007376:Interleukin-2